You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Zanubrutinib

Showing 1 - 25 of 104
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteers Trial in Daytona Beach, Dallas (Zanubrutinib)

Recruiting
  • Healthy Volunteers
  • Zanubrutinib
  • Daytona Beach, Florida
  • +1 more
Mar 15, 2023

Mantle Cell Lymphoma Trial in Miami, Houston (Zanubrutinib, Tafasitamab)

Not yet recruiting
  • Mantle Cell Lymphoma
  • Miami, Florida
  • +1 more
Aug 31, 2023

Primary Membranous Nephropathy Trial (Zanubrutinib, Tacrolimus)

Not yet recruiting
  • Primary Membranous Nephropathy
  • (no location specified)
Jan 23, 2023

CLL Trial (Sonrotoclax, Zanubrutinib, Venetoclax)

Not yet recruiting
  • CLL
  • (no location specified)
Oct 3, 2023

Healthy Volunteers Trial in Daytona Beach, Dallas (Zanubrutinib)

Completed
  • Healthy Volunteers
  • Zanubrutinib
  • Daytona Beach, Florida
  • +1 more
Jan 27, 2023

Waldenström's Macroglobulinemia Trial (zanubrutinib,bendamustine,rituximab)

Not yet recruiting
  • Waldenström's Macroglobulinemia
  • (no location specified)
Aug 4, 2023

PCNSL Trial in Shanghai (Zanubrutinib, Rituximab, Methotrexate)

Not yet recruiting
  • PCNSL
  • Zanubrutinib
  • +3 more
  • Shanghai, Shanghai, China
    Ruijin Hospital
Jun 8, 2023

Warm Autoimmune Hemolytic Anemia Trial in Beijing (Zanubrutinib)

Not yet recruiting
  • Warm Autoimmune Hemolytic Anemia
  • Zanubrutinib
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jun 20, 2023

Refractory/Relapsed Autoimmune Hemolytic Anemia Trial in Tianjin (Zanubrutinib)

Not yet recruiting
  • Refractory/Relapsed Autoimmune Hemolytic Anemia
  • Zanubrutinib
  • Tianjin, Tianjin, China
    Regenerative Medicine Center
Aug 27, 2023

Lymphoma, Mantle-Cell Trial in Shanghai (Zanubrutinib, Rituximab, Bendamustin)

Not yet recruiting
  • Lymphoma, Mantle-Cell
  • Zanubrutinib
  • +2 more
  • Shanghai, Shanghai, China
    Ruijin Hospital
Nov 14, 2023

Waldenstrom Macroglobulinemia Trial in Tianjin (Zanubrutinib, Bendamustine and Rituximab)

Recruiting
  • Waldenstrom Macroglobulinemia
  • Zanubrutinib, Bendamustine and Rituximab
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jun 13, 2023

Lymphoma Trial in Worldwide (Zanubrutinib Oral Capsule)

Not yet recruiting
  • Lymphoma
  • Zanubrutinib Oral Capsule
  • Leuven, Belgium
  • +8 more
Sep 27, 2023

Diffuse Large B Cell Lymphoma Trial in Wuhan (Zanubrutinib plus RCHOP)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Zanubrutinib plus RCHOP
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Aug 16, 2023

Mantle Cell Lymphoma Trial (drug, biological, other, procedure)

Not yet recruiting
  • Mantle Cell Lymphoma
  • Zanubrutinib
  • +11 more
  • (no location specified)
Jul 26, 2023

Diffuse Large B Cell Lymphoma Trial in Shenyang (Zanubrutinib, Rituximab, Cyclophosphamide)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • Zanubrutinib
  • +5 more
  • Shenyang, Liaoning, China
    Xing Xiaojing
Jun 1, 2023

Monoclonal Gammopathy of Uncertain Significance Trial in Utrecht (Zanubrutinib Oral Product)

Not yet recruiting
  • Monoclonal Gammopathy of Uncertain Significance
  • Zanubrutinib Oral Product
  • Utrecht, Netherlands
    University Medical Center Utrecht
Jul 6, 2023

Waldenstrom Macroglobulinemia Trial (Zanubrutinib)

Not yet recruiting
  • Waldenstrom Macroglobulinemia
  • Zanubrutinib
  • (no location specified)
Nov 28, 2022

Mantle Cell Lymphoma Trial (Zanubrutinib, Rituximab)

Not yet recruiting
  • Mantle Cell Lymphoma
  • (no location specified)
Nov 22, 2022

Untreated Mantle Cell Lymphoma Trial in Suzhou (zanubrutinib and rituximab, BEAM pretreatment, zanubrutinib maintenance)

Recruiting
  • Untreated Mantle Cell Lymphoma
  • zanubrutinib and rituximab
  • +2 more
  • Suzhou, Jiangsu, China
    the First Affiliated Hospital of Soochow University
Aug 16, 2022

Splenic Marginal Zone Lymphoma Trial in Worldwide (Rituximab, Zanubrutinib)

Not yet recruiting
  • Splenic Marginal Zone Lymphoma
  • Aarhus, Denmark
  • +4 more
Feb 17, 2023

Diffuse Large B Cell Lymphoma | DLBCL Recurrent/Refractory Trial (ZR2-ICE)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma | Diffuse Large B-Cell Lymphoma Recurrent/Refractory
  • (no location specified)
Sep 5, 2023

Diffuse Large B-cell Lymphoma (DLBCL) Trial in Lanzhou (Zanubrutinib)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma (DLBCL)
  • Zanubrutinib
  • Lanzhou, Gansu, China
    The First Hospital of Lanzhou University
Oct 23, 2022

CNS Lymphoma Trial in Beijing (Zanubrutinib)

Recruiting
  • CNS Lymphoma
  • Zanubrutinib
  • Beijing, Beijing, China
    Peking University People's Hospital
Aug 1, 2022

Leukemia, Lymphocytic, Chronic, B-Cell Trial in New York (Zanubrutinib Pill, Venetoclax Pill, Obinutuzumab Injection)

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Zanubrutinib Pill
  • +2 more
  • New York, New York
    Weill Cornell Medicine/NewYork-Presberteryian Hospital
Dec 6, 2022

Diffuse Large B Cell Lymphoma Trial in Shanghai (Zanubrutinib, Polatuzumab vedotin and Rituximab)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Zanubrutinib, Polatuzumab vedotin and Rituximab
  • Shanghai, Shanghai, China
    Zhongshan Hospital，Fudan University
Jul 10, 2023